Given the ready availability of inhibitors of RIPK1/RIPK3 and the large clinical impact of venous thrombosis annually worldwide, the mechanistic relationship between RIPK1/RIPK3/MLKL, platelets, NETosis and venous thrombosis certainly merits further investigation. Here, MLKL is linked to Venous thrombosis.